home / stock / aciu / aciu short
Short Information | AC Immune SA (NASDAQ:ACIU)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 330,629 |
Total Actual Volume | 5,490,207 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 16,531 |
Average Short Percentage | 8.05% |
Is there a ACIU Short Squeeze or Breakout about to happen?
See the ACIU Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-23-2024 | $2.45 | $2.38 | $2.51 | $2.37 | 189,450 | 17,059 | 9% |
04-22-2024 | $2.39 | $2.42 | $2.51 | $2.355 | 208,131 | 21,813 | 10.48% |
04-19-2024 | $2.4 | $2.36 | $2.49 | $2.311 | 316,801 | 10,075 | 3.18% |
04-18-2024 | $2.41 | $2.38 | $2.49 | $2.36 | 369,340 | 6,222 | 1.68% |
04-17-2024 | $2.45 | $2.42 | $2.69 | $2.42 | 250,553 | 14,685 | 5.86% |
04-16-2024 | $2.49 | $2.45 | $2.54 | $2.45 | 168,401 | 7,390 | 4.39% |
04-15-2024 | $2.73 | $2.52 | $2.7991 | $2.49 | 113,095 | 13,037 | 11.53% |
04-12-2024 | $2.76 | $2.74 | $2.77 | $2.69 | 39,028 | 3,828 | 9.81% |
04-11-2024 | $2.79 | $2.73 | $3.02 | $2.71 | 124,110 | 18,770 | 15.12% |
04-10-2024 | $2.8 | $2.8 | $2.9 | $2.69 | 173,791 | 16,848 | 9.69% |
04-09-2024 | $2.84 | $2.8 | $2.8753 | $2.7509 | 229,991 | 28,882 | 12.56% |
04-08-2024 | $2.79 | $2.8 | $2.8496 | $2.69 | 302,303 | 18,050 | 5.97% |
04-05-2024 | $2.74 | $2.75 | $2.84 | $2.72 | 1,123,939 | 6,552 | 0.58% |
04-04-2024 | $2.84 | $2.75 | $2.8601 | $2.73 | 30,061 | 1,603 | 5.33% |
04-03-2024 | $2.71 | $2.8 | $2.86 | $2.64 | 112,507 | 15,278 | 13.58% |
04-02-2024 | $2.74 | $2.7 | $2.785 | $2.56 | 194,455 | 19,559 | 10.06% |
04-01-2024 | $3 | $2.73 | $3 | $2.68 | 197,724 | 14,199 | 7.18% |
03-28-2024 | $3.07 | $2.96 | $3.18 | $2.93 | 168,448 | 17,803 | 10.57% |
03-27-2024 | $2.83 | $3.03 | $3.17 | $2.83 | 193,211 | 15,362 | 7.95% |
03-26-2024 | $2.95 | $2.84 | $3.03 | $2.65 | 984,868 | 63,614 | 6.46% |
News, Short Squeeze, Breakout and More Instantly...
AC Immune SA Company Name:
ACIU Stock Symbol:
NASDAQ Market:
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update ACI-24.060 ABATE Phase 2 trial to report Abeta-PET imaging results in Q2 and H2 ACI-7104.056 VacSYn Phase 2 trial in Parkinson’s disease on track for interim data in H2 ACI-24.060 for Alzheim...
AC Immune Announces Upcoming Presentations at AD/PD™ 2024 Multiple presentations at the International Conference on Alzheimer's and P...
AC Immune to Regain Global Rights to Crenezumab and Semorinemab Company’s strategy is focused on advancing the Phase 2 development of its three active immunotherapies Active immunotherapy now considered to be the optimal approach for precision prevention of neurodegenerative di...